title: Workshop on partial breast irradiation: state of the art and the science, Bethesda, MD, December 8-10, 2002.
abstract: Breast conserving surgery followed by radiation therapy has been accepted as an alternative to mastectomy in the management of patients with early-stage breast cancer. Over the past decade there has been increasing interest in a variety of radiation techniques designed to treat only the portion of the breast deemed to be at high risk for local recurrence (partial-breast irradiation [PBI]) and to shorten the duration of treatment (accelerated partial-breast irradiation [APBI]). To consider issues regarding the equivalency of the various radiation therapy approaches and to address future needs for research, quality assurance, and training, the National Cancer Institute, Division of Cancer Treatment and Diagnosis, Radiation Research Program, hosted a Workshop on PBI in December 2002. Although 5- to 7-year outcome data on patients treated with PBI and APBI are now becoming available, many issues remain unresolved, including clinical and pathologic selection criteria, radiation dose and fractionation and how they relate to the standard fractionation for whole breast irradiation, appropriate target volume, local control within the untreated ipsilateral breast tissue, and overall survival. This Workshop report defines the issues in relation to PBI and APBI, recommends parameters for consideration in clinical trials and for reporting of results, serves to enhance dialogue among the advocates of the various radiation techniques, and emphasizes the importance of education and training in regard to results of PBI and APBI as they become emerging clinical treatments.
authors.affiliation: Radiation Research Program, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
authors.forename: P
authors.initials: P
authors.lastname: Wallner
authors.forename: D
authors.initials: D
authors.lastname: Arthur
authors.forename: H
authors.initials: H
authors.lastname: Bartelink
authors.forename: J
authors.initials: J
authors.lastname: Connolly
authors.forename: G
authors.initials: G
authors.lastname: Edmundson
authors.forename: A
authors.initials: A
authors.lastname: Giuliano
authors.forename: N
authors.initials: N
authors.lastname: Goldstein
authors.forename: J
authors.initials: J
authors.lastname: Hevezi
authors.forename: T
authors.initials: T
authors.lastname: Julian
authors.forename: R
authors.initials: R
authors.lastname: Kuske
authors.forename: A
authors.initials: A
authors.lastname: Lichter
authors.forename: B
authors.initials: B
authors.lastname: McCormick
authors.forename: R
authors.initials: R
authors.lastname: Orecchia
authors.forename: L
authors.initials: L
authors.lastname: Pierce
authors.forename: S
authors.initials: S
authors.lastname: Powell
authors.forename: L
authors.initials: L
authors.lastname: Solin
authors.forename: F
authors.initials: F
authors.lastname: Vicini
authors.forename: T
authors.initials: T
authors.lastname: Whelan
authors.forename: J
authors.initials: J
authors.lastname: Wong
authors.forename: C N
authors.initials: CN
authors.lastname: Coleman
mesh_terms: D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D002170:Canada; D017326:Clinical Trials, Phase III as Topic; D005060:Europe; D005260:Female; D006801:Humans; D015412:Mastectomy, Segmental; D018579:Patient Selection; D011878:Radiotherapy / Q000379:methods; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D014481:United States